Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Publikationen
Suchbegriffe: CARDIOMEGALY - DRUG THERAPY , . Treffer: 5
2018
Harper, SC; Johnson, J; Borghetti, G; Zhao, H; Wang, T; Wallner, M; Kubo, H; Feldsott, EA; Yang, Y; Joo, Y; Gou, X; Sabri, AK; Gupta, P; Myzithras, M; Khalil, A; Franti, M; Houser, SR
GDF11 Decreases Pressure Overload-Induced Hypertrophy, but Can Cause Severe Cachexia and Premature Death.
Circ Res. 2018; 123(11):1220-1231
Doi: 10.1161/CIRCRESAHA.118.312955
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2015
Lee, DI; Zhu, G; Sasaki, T; Cho, GS; Hamdani, N; Holewinski, R; Jo, SH; Danner, T; Zhang, M; Rainer, PP; Bedja, D; Kirk, JA; Ranek, MJ; Dostmann, WR; Kwon, C; Margulies, KB; Van Eyk, JE; Paulus, WJ; Takimoto, E; Kass, DA
Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease.
Nature. 2015; 519(7544):472-476
Doi: 10.1038/nature14332
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2014
Bisping, E; Wakula, P; Poteser, M; Heinzel, FR
Targeting cardiac hypertrophy: toward a causal heart failure therapy.
J Cardiovasc Pharmacol. 2014; 64(4):293-305
Doi: 10.1097/FJC.0000000000000126
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2007
Antoons, G; Oros, A; Bito, V; Sipido, KR; Vos, MA
Cellular basis for triggered ventricular arrhythmias that occur in the setting of compensated hypertrophy and heart failure: considerations for diagnosis and treatment.
J Electrocardiol. 2007; 40(6 Suppl):S8-14
Doi: 10.1016/j.jelectrocard.2007.05.022
Web of Science
PubMed
FullText
FullText_MUG
1990
Löw-Friedrich, I; Grützmacher, P; März, W; Bergmann, M; Schoeppe, W
Long-term echocardiographic examinations in chronic hemodialysis patients substituted with recombinant human erythropoietin.
Blood Purif. 1990; 8(5):272-278
Doi: 10.1159/000169978
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar